Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
BioConferenceLive

Insulin Resistance Also Mediated by White Blood Cells

By BiotechDaily International staff writers
Posted on 13 Aug 2012
Image: False-color scanning electron micrograph (SEM) of a neutrophil (Photo courtesy of UC San Diego School of Medicine).
Image: False-color scanning electron micrograph (SEM) of a neutrophil (Photo courtesy of UC San Diego School of Medicine).
Researchers have now found that neutrophils play a role in mediating the development of insulin resistance, the central characteristic of type 2 diabetes. The discovery also provides a potential new treatment target.

Using live mouse models as well as cultured liver and fat cells, a study team based at the University of California, San Diego, School of Medicine (La Jolla, CA, USA) discovered that an enzyme secreted by neutrophils called neutrophil elastase (NE) impairs insulin signaling and boosts resistance. Conversely, deletion of NE in obese mice fed a high-fat diet improved insulin sensitivity. “These results are largely unexpected. Although several immune cells have been established in the etiology of insulin resistance, the role of neutrophils in this process has remained unclear until now,” said Da Young Oh, co-author and assistant project scientist in the laboratory of study leader Jerrold M. Olefsky, MD and professor of medicine.

Chronic low-grade inflammation is an important cause of systemic insulin resistance. Neutrophils are the first immune cells to respond to tissue inflammation and can promote chronic inflammation by helping to recruit additional white blood cells - macrophages. Oh noted that neutrophils were considered to be “transient infiltrates” incapable of sustaining chronic, low-grade inflammation. “Our studies now suggest neutrophils possess powerful immune modulatory effects,” Oh said. Specifically, neutrophils use NE to activate a signaling pathway that triggers macrophages to secrete proinflammatory cytokines. NE degrades IRS1, a key protein in the insulin-signaling pathway in both liver and fat cells. The scientists noted that although NE has been shown to degrade this protein in lung cancer cells, the effect on insulin target tissues such as liver and adipose is striking.

The insulin-mediating role of neutrophils makes them a new target for developing treatments of insulin resistance in particular and diabetes in general. “One could, in theory, take an NE activity inhibitory approach to reverse or improve insulin resistance,” Oh said, noting that NE inhibiting drugs are already used for treatment of emphysema in Japan and are being tested in the United States for both emphysema and type 1 diabetes.

The findings have been reported in the August 5, 2012, advance online edition of the journal Nature Medicine.

Related Links:

University of California, San Diego, School of Medicine



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Lab Technologies

view channel

Precise Ion Irradiation Dosing Method Developed for Cancer Therapy

Scientists are employing nuclear physics principles to provide more effective approaches to radiotherapy treatment for cancer patients. Radiation therapy using heavy ions is best suitable for cancer patients with tumors that are difficult to access, such as in the brain. These particles scarcely damage the penetrated... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.